000			02335 a2200685 4500
005			20250518071324.0
264		0	_c20210428
008			202104s 0 0 eng d
022			_a1872-6968
024	7		_a10.1016/j.clineuro.2019.105568 _2doi
040			_aNLM _beng _cNLM
100	1		_aMukherjee, Soumya
245	0	0	_aCraniotomy for recurrent glioblastoma: Is it justified? A comparative cohort study with outcomes over 10 years. _h[electronic resource]
260			_bClinical neurology and neurosurgery _c01 2020
300			_a105568 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAge Factors
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents, Alkylating _xtherapeutic use
650	0	4	_aAntineoplastic Agents, Immunological _xtherapeutic use
650	0	4	_aBevacizumab _xtherapeutic use
650	0	4	_aBrain Neoplasms _xphysiopathology
650	0	4	_aChemoradiotherapy
650	0	4	_aChemoradiotherapy, Adjuvant
650	0	4	_aChemotherapy, Adjuvant
650	0	4	_aCohort Studies
650	0	4	_aCraniotomy
650	0	4	_aDNA Methylation
650	0	4	_aDNA Modification Methylases _xgenetics
650	0	4	_aDNA Repair Enzymes _xgenetics
650	0	4	_aFemale
650	0	4	_aGlioblastoma _xphysiopathology
650	0	4	_aHumans
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aKarnofsky Performance Status
650	0	4	_aLomustine _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Recurrence, Local _xphysiopathology
650	0	4	_aNeurosurgical Procedures
650	0	4	_aPromoter Regions, Genetic
650	0	4	_aProportional Hazards Models
650	0	4	_aProspective Studies
650	0	4	_aQuality of Life
650	0	4	_aRadiotherapy
650	0	4	_aRadiotherapy, Adjuvant
650	0	4	_aReoperation
650	0	4	_aSurvival Rate
650	0	4	_aTemozolomide _xtherapeutic use
650	0	4	_aTumor Suppressor Proteins _xgenetics
650	0	4	_aYoung Adult
700	1		_aWood, Joseph
700	1		_aLiaquat, Imran
700	1		_aStapleton, Simon R
700	1		_aMartin, Andrew J
773	0		_tClinical neurology and neurosurgery _gvol. 188 _gp. 105568
856	4	0	_uhttps://doi.org/10.1016/j.clineuro.2019.105568 _zAvailable from publisher's website
999			_c30324714 _d30324714